Prometheus Biosciences Inc (RXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2017 | |
| Sales | 359 | 179 | 228 | 0 | 0 |
| Gross Profit | 359 | 179 | 228 | N/A | N/A |
| Operating Expenses | 7,825 | 6,733 | 6,652 | 0 | 28,210 |
| Operating Income | -7,466 | -6,554 | -6,424 | N/A | -28,210 |
| Interest Expense | 364 | 595 | 534 | 0 | 853 |
| Other Income | 4 | -2 | 4 | 0 | 460 |
| Pre-tax Income | -7,826 | -7,151 | -6,954 | 0 | -28,603 |
| Net Income Continuous | -7,826 | -7,151 | -6,954 | N/A | -28,603 |
| Net Income Discontinuous | 879 | -1,289 | -6,174 | N/A | N/A |
| Net Income | $-6,947 | $-8,440 | $-13,128 | $N/A | $-28,603 |
| EPS Basic Total Ops | -4.55 | -5.93 | -9.56 | N/A | -0.51 |
| EPS Basic Continuous Ops | -5.13 | -5.02 | -5.06 | N/A | -0.51 |
| EPS Basic Discontinuous Ops | 0.58 | -0.90 | -4.50 | N/A | N/A |
| EPS Diluted Total Ops | -4.55 | -5.93 | -9.56 | N/A | -0.51 |
| EPS Diluted Continuous Ops | -5.13 | -5.02 | -5.06 | N/A | -0.51 |
| EPS Diluted Discontinuous Ops | 0.58 | -0.90 | -4.50 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | N/A | N/A | -0.51 |
| EBITDA(a) | $-7,436 | $-6,527 | $-6,402 | $N/A | $-27,568 |